Medtronic plc (LON: 0Y6X)

London flag London · Delayed Price · Currency is GBP · Price in USD
88.19
-0.18 (-0.20%)
Jan 22, 2025, 7:14 PM BST
1.99%
Market Cap 91.45B
Revenue (ttm) 25.42B
Net Income (ttm) 3.30B
Shares Out n/a
EPS (ttm) 2.52
PE Ratio 27.69
Forward PE n/a
Dividend 2.18 (2.47%)
Ex-Dividend Date Dec 27, 2024
Volume 3,556
Average Volume 10,682
Open 87.78
Previous Close 88.37
Day's Range 87.56 - 88.46
52-Week Range 68.87 - 91.91
Beta 0.85
RSI 70.26
Earnings Date Feb 18, 2025

About Medtronic

Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. The Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves, surgical valve replacement and repair products, endovascular stent grafts and accesso... [Read more]

Industry Medical - Equipment & Services
Sector Healthcare
Founded 1949
Employees 95,000
Stock Exchange London Stock Exchange
Ticker Symbol 0Y6X
Full Company Profile

Financial Performance

In 2024, Medtronic's revenue was $32.36 billion, an increase of 3.64% compared to the previous year's $31.23 billion. Earnings were $3.68 billion, a decrease of -2.18%.

Financial numbers in USD Financial Statements

News

J&J Falls — While Boston Scientific, Medtronic Pop — After Strokes Sideline A Key Product

Johnson & Johnson stock skidded Wednesday after the company temporarily paused sales of its pulsed field ablation system.

14 days ago - Investor's Business Daily

Is Medtronic's Dividend Safe?

14 days ago - The Motley Fool

Kuros Biosciences USA, Inc. Announces an Exclusive Strategic Agreement with the Medtronic Spinal Division

Medtronic will act as the exclusive sales agent of MagnetOsTM for Kuros Biosciences USA, Inc. in mutually agreed upon sales territories for use in spine surgeries Kuros will work collaboratively to se...

16 days ago - Accesswire

Medtronic Chairman and CEO Geoff Martha to speak at J.P. Morgan healthcare conference

GALWAY, Ireland , Jan. 6, 2025 /PRNewswire/ -- Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today announced it will participate in the 43rd annual J.P. Morgan healthcare confere...

16 days ago - PRNewsWire

2 Cheap Dividend Aristocrats to Buy for 2025

#Morningstar  #DividendArtisocrats #StockInvesting These reliable dividend stocks look significantly undervalued today. 00:00 Introduction 00:39 Federal Realty Trust FRT 01:25 Medtronic MDT Susan Dziu...

22 days ago - Morningstar

My Best Dividend Aristocrats For January 2025

The ProShares S&P 500 Dividend Aristocrat ETF rocked a cool 4.85% gain in November, but it's giving up nearly half of its return this year in December. I present 3 strategies that can theoretically be...

22 days ago - Seeking Alpha

Medtronic Stock Is Still A Great "Buy"

Financial writer predicts Medtronic's stock will rise due to recent product launches and improved margins, reaffirming a Buy rating for 2025.

4 weeks ago - Seeking Alpha

Looking Into Medtronic's Recent Short Interest

Medtronic's (NYSE: MDT) short percent of float has fallen 16.13% since its last report. The company recently reported that it has 10.01 million shares sold short , which is 0.78% of all regular share...

4 weeks ago - Benzinga

Jim Cramer takes a closer look at the medtech space

'Mad Money' host Jim Cramer takes a closer look at Medtronic, Edwards, and Idexx.

5 weeks ago - CNBC

Medtronic continues losses for seven straight sessions

Medtronic (MDT) shares continue to decline, but analysts are still bullish on the stock despite concerns about the company's bottom line.

6 weeks ago - Seeking Alpha

Buy 1 December Aristocrat Of 67 From 38 With 'Safer' Dividends

"Dividend Aristocrats

6 weeks ago - Seeking Alpha

Medtronic PLC (MDT) Announces Third Quarter Cash Dividend for Fiscal Year 2025

Medtronic PLC (MDT) Announces Third Quarter Cash Dividend for Fiscal Year 2025

6 weeks ago - GuruFocus

Medtronic announces cash dividend for third quarter of fiscal year 2025

GALWAY, Ireland , Dec. 5, 2024 /PRNewswire/ -- The board of directors of Medtronic plc (NYSE: MDT) on Thursday, December 5, 2024, approved the company's cash dividend for the third quarter of fiscal y...

6 weeks ago - PRNewsWire

Acutus Medical announces workforce reduction by 70%

Acutus Medical (AFIB) to reduce workforce by 70% and focus on supporting Medtronic products.

7 weeks ago - Seeking Alpha

Price Over Earnings Overview: Medtronic

Looking into the current session, Medtronic Inc. (NYSE: MDT) shares are trading at $85.62, after a 1.06% decrease. Over the past month, the stock fell by 4.53% , but over the past year, it actually i...

7 weeks ago - Benzinga

Best Long-Term Investment Stocks to Buy

Some of the best long-term investment stocks include companies that are in good financial standing, have a low valuation and pay consistent dividends.

7 weeks ago - Kiplinger

Should You Pick Medtronic Stock At $85?

Medtronic (NYSE: MDT) reported its Q2 fiscal 2025 results (fiscal ends in April) last week, with revenues and earnings exceeding the street estimates. The company reported revenue of $8.4 billion and ...

2 months ago - Forbes

The Best Large-Cap Stocks to Buy

Large-cap stocks are key additions to any well-rounded portfolio, but how do you find the best ones? We take a closer look here.

2 months ago - Kiplinger

Starbucks To Rally Around 13%? Here Are 10 Top Analyst Forecasts For Tuesday

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page . Stifel ra...

2 months ago - Benzinga

Medtronic receives FDA clearance for new InPen™ app, paving the way for its Smart MDI system launch with Simplera™ CGM

New Smart MDI system will be the first system to deliver real-time, personalized insights on when and how much to dose including for missed or inaccurate mealtime doses. GALWAY, Ireland , Nov. 20, 202...

2 months ago - PRNewsWire

Medtronic Q3 Earnings: A Solid Performance, But Bottom Line Still Needs Fixing

Medtronic plc reported Q2 earnings today, with revenues of $8.4bn, up 5% year-on-year, adjusted EPS of $1.26, supported by a dividend yielding 3.2%. Despite consistent mid-single-digit revenue growth ...

2 months ago - Seeking Alpha

Gold Moves Higher; Medtronic Posts Upbeat Results

U.S. stocks traded mixed toward the end of trading, with the Nasdaq Composite gaining by around 1% on Tuesday.

2 months ago - Benzinga